Paragraphs
TIME IN RANGE IS A VALUABLE INDICATOR OF GLYCEMIC CONTROL AND PATIENT RISK
Selector Id
section-runner-mature-women
Selector Class
section-runner-mature-women section-textover-bluebg
Glucose control influences macrovascular disease,¹ mortality and cardiovascular disease in T1DM.² A1C is the established reference marker for assessing glucose control, but additional biomarkers and measures may aid in making a more precise evaluation of control and complications risk than A1C alone.³
Selector Id
section-glucose-control-influences
Selector Class
section-glucose-control-influences
Time in range is a valuable predictor of patient risk and outcomes⁴
- $1.6B estimated annual costs for hypoglycemia-related hospitalizations in the US.⁵
- Time in range is strongly associated with lower risk of complications.⁶
- A TIR of 70% and 50% corresponded with an average A1C of approximately 7% and 8%, respectively.⁷
Selector Class
section-valuable-predictor
Eversense patients achieve a median 63% time in range8
UNIQUELY DESIGNED TO IMPROVE GLYCEMIC AWARENESS. DAY AND NIGHT.
Selector Class
section-patients-achieve
To find out more about our real-world time in range data, download our study: Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor
Selector Class
product-sheet
Selector Class
section-next
Selector Class
section-lists
Sub Description
The advanced sensor technology and under-the-skin placement help patients reach unprecedented levels of wear time, leading to improved clinical outcomes.